Management Board meeting: 16 March 2023
Table of contents
Date:
16/03/2023
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
-
List item
Agenda for the 119th meeting of the Management Board: 16 March 2023 (PDF/145.32 KB)
Adopted
First published: 16/03/2023
Last updated: 20/03/2023
EMA/MB/948302/2022 -
List item
2022 annual report of the European Medicines Agency (PDF/9.52 MB) (new)
Adopted
First published: 15/05/2023 -
List item
Outcome of written procedures finalised during the period from 6 December 2022 to 8 March 2023 (PDF/145.2 KB)
First published: 20/03/2023
EMA/MB/948919/2022 -
List item
2022 European Medicines Agency annual report on independence (PDF/440.92 KB)
Adopted
First published: 21/03/2023
EMA/2588/2023 -
List item
2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission (PDF/924.25 KB)
First published: 21/03/2023
EMA/900566/2022 -
List item
Rules for reimbursement of expenses for delegates attending meetings with effect from 17 March 2023 (PDF/188.7 KB)
Adopted
First published: 17/03/2017
Last updated: 22/03/2023
EMA/MB/279597/2018 Rev. 4 -
List item
Rules for the implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures - Revised implementing rules to the Fee Regulation as of 1 April 2023 (PDF/445.33 KB)
First published: 31/03/2023
EMA/MB/622516/2022 -
List item
Rules for the implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures - Revised implementing rules to the Fee Regulation as of 1 May 2023 (PDF/361.57 KB) (new)
Adopted
First published: 10/05/2023
EMA/MB/118263/2023